Upcoming Events

We have not entered the dystopian “Brave New World” described by Aldous Huxley…but artificial intelligence (“AI”) is certainly a game changer. At its core, AI is the ability of a digital algorithm (essentially, a computer) to mimic certain functions of human intelligence. AI is touching all aspects of the DME supplier’s operations, including (i) e-prescribing, (ii) patient adherence, (iii) inventory control and resupply management, (iv) billing and prior authorization management, and (v) implementation of predictive patient ordering models. AI is increasingly being used by governmental agencies to investigate fraud and abuse. Examples are (i) flagging high risk prescription activity, (ii) flagging improper reimbursement claims, and (iii) improved coverage and pricing transparency. As stated in its June 23, 2026 press release, the Department of Justice stated: “To enhance the deployment of advanced analytic to target health care fraud…the Fraud Division will be provided cloud computing space in the CMS Integrated Data Repository environment in which to deploy advanced data analytics algorithms and artificial tools.” This program will (i) discuss existing and proposed federal regulations of AI, (ii) discuss examples of state regulations of AI, (iii) how DME suppliers can use AI to streamline operations and promote efficiency, and (iv) legal pitfalls DME suppliers need to be aware of as they utilize AI.